Are complex karyotypes reliable prognostic markers for CLL?
Why are charity-funded early career research fellowships important in leukemia research?
What leads to shorter progression-free survival in CLL patients?
Changing epigenetic markers in CLL patients on ibrutinib
Enhancing immunotherapy for CLL patients with ibrutinib